Literature DB >> 1987685

The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation.

A M D'Alessandro1, M Kalayoglu, H W Sollinger, R M Hoffmann, A Reed, S J Knechtle, J D Pirsch, G R Hafez, D Lorentzen, F O Belzer.   

Abstract

Methods of accurately assessing the suitability of donor livers prior to transplantation are required if the incidence of primary nonfunction (PNF) is to be reduced. This study evaluated the ability of donor liver biopsies to predict the development of primary nonfunction after transplantation. From June 1987 until May 1990, 170 liver transplants were performed in 147 patients. A total of 124 donor liver biopsies were obtained and divided into three groups. Group 1 biopsies (n = 77) were obtained after revascularization of the liver, group 2 biopsies (n = 19) were obtained prior to donor hepatectomy but examined only after implantation, and group 3 biopsies (n = 28) were obtained as in group 2, but were examined prior to implantation. Three of 89 (3.4%) livers interpreted as having normal histology developed primary nonfunction, while one of 26 (3.8%) biopsies interpreted as having a minimal or moderate amount of fatty infiltration developed primary nonfunction. PNF occurred in 7 of 8 livers with severe fatty infiltration (3), hydropic degeneration (3), and centrilobular necrosis (1). A fourth liver with hydropic degeneration and poor function ultimately failed requiring retransplantation 8 weeks later. Analysis of liver function revealed progressive elevation in aspartate-aminotransferase, alanine-aminotransferase, lactate dehydrogenase, and serum ammonia (NH3) with increasing degrees of fatty infiltration. Donor age and weight was also found to be significantly higher in livers with fatty infiltration. This study suggests that donor liver biopsies demonstrating normal histology or minimal-to-moderate fatty infiltration function adequately, but that donor livers with severe fatty infiltration or hydropic degeneration function poorly and should not be transplanted.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1987685     DOI: 10.1097/00007890-199101000-00024

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  50 in total

1.  Liver regeneration is not altered in patients with nonalcoholic steatohepatitis (NASH) when compared to chronic hepatitis C infection with similar grade of inflammation.

Authors:  Osamah Hussein; Sergio Szvalb; L M Van den Akker-Berman; Nimer Assy
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

2.  Frozen section diagnosis in donor liver biopsies: observer variation of semiquantitative and quantitative steatosis assessment.

Authors:  Stefan Biesterfeld; Jasmin Knapp; Fernando Bittinger; Heiko Götte; Martin Schramm; Gerd Otto
Journal:  Virchows Arch       Date:  2012-07-08       Impact factor: 4.064

3.  Liver regeneration in donors evaluated by Tc-99m-GSA scintigraphy after living donor liver transplantation.

Authors:  Masaki Kaibori; Sang Kil Ha-Kawa; Yoichiro Uchida; Morihiko Ishizaki; Takamichi Saito; Kosuke Matsui; Junko Hirohara; Koichi Tanaka; Yasuo Kamiyama
Journal:  Dig Dis Sci       Date:  2007-08-04       Impact factor: 3.199

4.  The effect of hepatic ischemia reperfusion injury in a murine model of nonalcoholic steatohepatitis.

Authors:  Amit D Tevar; Callisia N Clarke; Rebecca Schuster; Jiang Wang; Michael J Edwards; Alex B Lentsch
Journal:  J Surg Res       Date:  2011-03-02       Impact factor: 2.192

5.  Computer-assisted liver graft steatosis assessment via learning-based texture analysis.

Authors:  Sara Moccia; Leonardo S Mattos; Ilaria Patrini; Michela Ruperti; Nicolas Poté; Federica Dondero; François Cauchy; Ailton Sepulveda; Olivier Soubrane; Elena De Momi; Alberto Diaspro; Manuela Cesaretti
Journal:  Int J Comput Assist Radiol Surg       Date:  2018-05-23       Impact factor: 2.924

6.  Postperfusion energy metabolism of steatotic graft and its relation to early graft viability following liver transplantation.

Authors:  C Miki; K Iriyama; D F Mirza; A D Mayer; J A Buckels; H Suzuki; P McMaster
Journal:  Dig Dis Sci       Date:  1998-01       Impact factor: 3.199

Review 7.  Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantation.

Authors:  Amit D Tevar; Calissia Clarke; Jiang Wang; Steven M Rudich; E Steve Woodle; Alex B Lentsch; Michael L Edwards
Journal:  J Am Coll Surg       Date:  2010-04       Impact factor: 6.113

Review 8.  Donor Hepatic Steatosis and Outcome After Liver Transplantation: a Systematic Review.

Authors:  Michael J J Chu; Anna J Dare; Anthony R J Phillips; Adam S J R Bartlett
Journal:  J Gastrointest Surg       Date:  2015-04-28       Impact factor: 3.452

9.  Morphometric analysis of hepatic steatosis in chronic hepatitis C infection.

Authors:  Alia Zubair; Shahid Jamal; Azhar Mubarik
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

10.  Insulin-like growth factor and epidermal growth factor treatment: new approaches to protecting steatotic livers against ischemia-reperfusion injury.

Authors:  Araní Casillas-Ramírez; Amine Zaouali; Susagna Padrissa-Altés; Ismail Ben Mosbah; Anna Pertosa; Izabel Alfany-Fernández; Maria Bintanel-Morcillo; Carme Xaus; Antoni Rimola; Juan Rodés; Joan Roselló-Catafau; Carmen Peralta
Journal:  Endocrinology       Date:  2009-03-12       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.